The company was founded in May 2010 and listed on the A-share main board in 2017. The company is committed to the comprehensive transformation of genetic testing technology to clinical application, focusing on the fields of reproductive health, genetic disease testing, scientific and technological services, tumor testing, etc., and has established a R&D, production, marketing, sales and customer service system according to international standards. The main business is genetic testing services based on high-throughput sequencing technology and sales of equipment and reagents related to genetic testing. The company's main products: medical testing services, basic research services, reagent sales, equipment sales. Corporate honors: The first prize of the 2016 Hunan Science and Technology Progress Award, China's Top 100 Unlisted Potential Enterprises, Top 100 Innovative Growth Enterprises, etc.
No Data
No Data